Inferensys

Glossary

Dynamic Prediction

The process of updating a patient's survival prognosis as new longitudinal data, such as repeated lab measurements, becomes available, often using landmarking or joint modeling.
Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.
LONGITUDINAL PROGNOSTIC UPDATING

What is Dynamic Prediction?

A statistical paradigm for continuously revising a patient's survival prognosis by integrating accumulating longitudinal biomarker data, such as repeated lab measurements or imaging results, into the predictive model.

Dynamic prediction is the process of updating an individual's predicted survival probability as new longitudinal data becomes available, moving beyond static baseline covariates. This methodology addresses the clinical reality that a patient's risk profile evolves over time based on their response to treatment and disease trajectory. The core statistical challenge is correctly associating a time-varying marker trajectory with the time-to-event outcome without introducing bias from measurement error or informative observation patterns.

Two dominant frameworks implement dynamic prediction: joint modeling and landmarking. Joint models couple a linear mixed-effects submodel for the longitudinal biomarker with a survival submodel, sharing a latent association structure to correct for endogenous measurement error. Landmarking, conversely, fits a standard Cox model at a series of pre-specified time points using only patients still at risk, conditioning on the most recent biomarker value as a fixed covariate. Both approaches generate dynamically updated survival curves that refine prognosis at each new clinical visit.

Longitudinal Prognostics

Key Characteristics of Dynamic Prediction

The defining features that distinguish dynamic prediction from static baseline models, enabling continuously updated patient risk assessments as new data arrives.

01

Longitudinal Data Integration

Unlike static models that rely on a single baseline snapshot, dynamic prediction ingests repeated measurements over time. This includes lab values, vital signs, or imaging biomarkers collected at irregular intervals. The model updates its understanding of the patient's trajectory, capturing the rate of change and variability in biomarkers rather than just a single value. This allows the system to detect acceleration in disease progression that a one-time measurement would miss.

02

Landmarking Methodology

A pragmatic approach where predictions are updated at specific landmark times (e.g., every 6 months). At each landmark, the model uses only patients still at risk and their most recent data. This avoids complex joint modeling and naturally handles time-varying covariates without parametric assumptions. It is computationally efficient for large electronic health record datasets and directly addresses the question: 'Given that the patient has survived to this point, what is their updated prognosis?'

03

Joint Modeling Architecture

A sophisticated statistical framework that simultaneously models the longitudinal biomarker trajectory and the time-to-event outcome. It typically links a linear mixed-effects submodel for the biomarker with a Cox proportional hazards submodel for survival. This corrects for endogenous measurement error—the fact that observed biomarker values are noisy snapshots of a true underlying process. The shared random effects capture the association between the trajectory and the hazard.

04

Dynamic Risk Prediction Window

Predictions are conditional on survival to the present and project risk over a fixed future horizon (e.g., 5-year risk from now). This sliding window approach provides clinically actionable timeframes. A patient's 5-year risk of cardiovascular event is recalculated at each visit, incorporating their latest cholesterol trends and blood pressure readings. This contrasts with static predictions made at diagnosis that become outdated as the patient's health evolves.

05

Handling Informative Dropout

Patients with worsening health are more likely to miss follow-up visits or withdraw from studies. This informative censoring biases static models. Dynamic prediction frameworks, particularly joint models, can account for this by modeling the dependence between the measurement process and the event risk. The model recognizes that a sudden absence of data may itself be a prognostic signal, preventing overly optimistic risk estimates for deteriorating patients.

06

Real-Time Clinical Decision Support

The ultimate output is a continuously updated, patient-specific survival curve that changes as new data flows in. This can be embedded in clinical dashboards or electronic health record alerts. For example, in oncology, a dynamic model might predict that a patient's risk of progression has crossed a threshold, triggering a recommendation for a treatment change or an earlier scan. This moves prognosis from a one-time statement to an ongoing monitoring tool.

DYNAMIC PREDICTION

Frequently Asked Questions

Explore the core concepts behind updating patient survival prognosis using longitudinal data streams, including landmarking and joint modeling approaches.

Dynamic prediction is the process of updating a patient's survival prognosis as new longitudinal data—such as repeated lab measurements, vital signs, or biomarker readings—becomes available over time. Unlike static baseline models that predict risk using only initial covariates, dynamic prediction incorporates the patient's evolving clinical trajectory. This is typically achieved through two primary statistical frameworks: landmarking, which fits a new survival model at each prediction time using only patients still at risk, and joint modeling, which simultaneously models the longitudinal biomarker process and the time-to-event outcome. The goal is to provide clinicians with a continuously refined, personalized risk assessment that reflects the patient's current health state rather than historical snapshots.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.